Bertazza L - Search Results

1

The dual role of tumor necrosis factor (TNF) in cancer biology.

Bertazza L, Mocellin S. Bertazza L, et al. Curr Med Chem. 2010;17(29):3337-3352. doi: 10.2174/092986710793176339. Curr Med Chem. 2010. PMID: 20712570 Review.

2

Tumor necrosis factor (TNF) biology and cell death.

Bertazza L, Mocellin S. Bertazza L, et al. Front Biosci. 2008 Jan 1;13:2736-43. doi: 10.2741/2881. Front Biosci. 2008. PMID: 17981749 Review.

3

Circulating tumor cells in solid cancer: tumor marker of clinical relevance?

Bertazza L, Mocellin S, Nitti D. Bertazza L, et al. Curr Oncol Rep. 2008 Mar;10(2):137-46. doi: 10.1007/s11912-008-0022-y. Curr Oncol Rep. 2008. PMID: 18377827 Review.

4

Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival.

Bertazza L, Mocellin S, Marchet A, Pilati P, Gabrieli J, Scalerta R, Nitti D. Bertazza L, et al. J Transl Med. 2009 Dec 22;7:111. doi: 10.1186/1479-5876-7-111. J Transl Med. 2009. PMID: 20028510 Free PMC article.

5

Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis.

Pilati P, Mocellin S, Bertazza L, Galdi F, Briarava M, Mammano E, Tessari E, Zavagno G, Nitti D. Pilati P, et al. Among authors: bertazza l. Ann Surg Oncol. 2012 Feb;19(2):402-8. doi: 10.1245/s10434-011-2132-2. Epub 2011 Nov 10. Ann Surg Oncol. 2012. PMID: 22071867

6

Circumventing melanoma chemoresistance by targeting DNA repair.

Mocellin S, Bertazza L, Benna C, Pilati P. Mocellin S, et al. Among authors: bertazza l. Curr Med Chem. 2012;19(23):3893-9. doi: 10.2174/092986712802002509. Curr Med Chem. 2012. PMID: 22788765 Review.

7

Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells.

Bertazza L, Barollo S, Radu CM, Cavedon E, Simioni P, Faggian D, Plebani M, Pelizzo MR, Rubin B, Boscaro M, Pezzani R, Mian C. Bertazza L, et al. J Cell Mol Med. 2015 Sep;19(9):2244-52. doi: 10.1111/jcmm.12612. Epub 2015 Jun 17. J Cell Mol Med. 2015. PMID: 26081844 Free PMC article.

8

Validation of miRNAs as diagnostic and prognostic biomarkers, and possible therapeutic targets in medullary thyroid cancers.

Mondin A, Bertazza L, Barollo S, Pedron MC, Manso J, Piva I, Basso D, Merante Boschin I, Iacobone M, Pezzani R, Mian C, Censi S. Mondin A, et al. Among authors: bertazza l. Front Endocrinol (Lausanne). 2023 Jun 8;14:1151583. doi: 10.3389/fendo.2023.1151583. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37361540 Free PMC article.

9

The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathways.

Barollo S, Bertazza L, Baldini E, Ulisse S, Cavedon E, Boscaro M, Pezzani R, Mian C. Barollo S, et al. Among authors: bertazza l. Invest New Drugs. 2014 Aug;32(4):626-35. doi: 10.1007/s10637-014-0108-3. Epub 2014 May 13. Invest New Drugs. 2014. PMID: 24821574

10

A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC.

Occhi G, Barollo S, Regazzo D, Bertazza L, Galuppini F, Guzzardo V, Jaffrain-Rea ML, Vianello F, Ciato D, Ceccato F, Watutantrige-Fernando S, Bisognin A, Bortoluzzi S, Pennelli G, Boscaro M, Scaroni C, Mian C. Occhi G, et al. Among authors: bertazza l. Oncotarget. 2015 Oct 13;6(31):32104-14. doi: 10.18632/oncotarget.5194. Oncotarget. 2015. PMID: 26392334 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page